These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18837989)

  • 1. Conflict and user involvement in drug misuse treatment decision-making: a qualitative study.
    Fischer J; Neale J; Bloor M; Jenkins N
    Subst Abuse Treat Prev Policy; 2008 Oct; 3():21. PubMed ID: 18837989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'They can't solve the problem without us': a qualitative study of stakeholder perspectives on user involvement in drug treatment services in England.
    Patterson S; Weaver T; Agath K; Albert E; Rhodes T; Rutter D; Crawford M
    Health Soc Care Community; 2009 Feb; 17(1):54-62. PubMed ID: 18564192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constructive conflict and staff consensus in substance abuse treatment.
    Melnick G; Wexler HK; Chaple M; Cleland CM
    J Subst Abuse Treat; 2009 Mar; 36(2):174-82. PubMed ID: 18657943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug consumption facility as part of a primary health care centre for problem drug users - which clients are attracted?
    Scherbaum N; Specka M; Bombeck J; Marrziniak B
    Int J Drug Policy; 2009 Sep; 20(5):447-9. PubMed ID: 19269803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are drug treatment services only for 'thieving junkie scumbags'? Drug users and the management of stigmatised identities.
    Radcliffe P; Stevens A
    Soc Sci Med; 2008 Oct; 67(7):1065-73. PubMed ID: 18640760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of worker values on client outcomes within a drug treatment service.
    Phillips R; Bourne H
    Int J Drug Policy; 2008 Feb; 19(1):33-41. PubMed ID: 18178394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of consensus within staff and client groups as well as concordance between staff and clients to treatment engagement.
    Melnick G; Wexler HK; Chaple M; Banks S
    J Subst Abuse Treat; 2006 Oct; 31(3):277-85. PubMed ID: 16996390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision-making in community-based paediatric physiotherapy: a qualitative study of children, parents and practitioners.
    Young B; Moffett JK; Jackson D; McNulty A
    Health Soc Care Community; 2006 Mar; 14(2):116-24. PubMed ID: 16460361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the early therapeutic alliance in the treatment of drug misuse.
    Meier PS; Donmall MC; Barrowclough C; McElduff P; Heller RF
    Addiction; 2005 Apr; 100(4):500-11. PubMed ID: 15784065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential sources of reinforcement and punishment in a drug-free treatment clinic: client and staff perceptions.
    Roll JM; Chudzynski JE; Richardson G
    Am J Drug Alcohol Abuse; 2005; 31(1):21-33. PubMed ID: 15768569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Treatment experienced' and 'treatment naïve' drug agency clients compared.
    Neale J; Robertson M; Bloor M
    Int J Drug Policy; 2007 Dec; 18(6):486-93. PubMed ID: 18061874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of counseling rapport and topics discussed in sessions with methadone treatment clients.
    Joe GW; Simpson DD; Rowan-Szal GA
    Subst Use Misuse; 2009; 44(1):3-17. PubMed ID: 19137479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.
    Treloar C; Rance J; Grebely J; Dore GJ
    Drug Alcohol Depend; 2013 Dec; 133(2):529-34. PubMed ID: 23932843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public sector managed care: a comparative evaluation of substance abuse treatment in three counties.
    Beattie M; McDaniel P; Bond J
    Addiction; 2006 Jun; 101(6):857-72. PubMed ID: 16696630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programme factors that influence completion of residential treatment.
    Meier PS; Best D
    Drug Alcohol Rev; 2006 Jul; 25(4):349-55. PubMed ID: 16854661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on evidence-based practice from consumers in the US public mental health system.
    Tanenbaum SJ
    J Eval Clin Pract; 2008 Oct; 14(5):699-706. PubMed ID: 19018898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criminal recidivism in three models of mandatory drug treatment.
    Young D; Fluellen R; Belenko S
    J Subst Abuse Treat; 2004 Dec; 27(4):313-23. PubMed ID: 15610833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat substance-using suicidal clients-how can we be helpful?
    Bergmans Y; Spence JM; Strike C; Links PS; Ball JS; Rufo C; Rhodes AE; Watson WJ; Eynan R
    Soc Work Health Care; 2009; 48(4):420-31. PubMed ID: 19396710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.